• News
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)

Metabolic dysfunction associated steatotic liver disease and the heart

Commentary by Dr. Marco Alings, MD PhD, Amphia Ziekenhuis, Breda; WCN, Utrecht; Scientific Officer at Julius ClinicalThe estimated prevalence of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in the adult population is 31% ...

By: Michelle Heuvelmans
  • Cardio-Metabolic and Renal Diseases

Upcoming webinar – Getting GRIP on MASH after LITMUS

On March 12th, we will organise the webinar: Getting GRIP on MASH after LITMUSDuring this webinar, our speaker and hosts will dive into the following topics:The usefulness of noninvasive diagnostic methods depends on the prevalence of t...

A brand-new look!

We are excited to announce that Julius Clinical has a brand-new look and website as part of the ongoing evolution of our company’s brand.Why? Ever since its foundation in 2008, Julius Clinical has been based on a unique triangle of scientif...

By: Michelle Heuvelmans

Webinar: “RSV and Asthma”

On September 6, our partner ReSViNET presented the webinar: “RSV and Asthma”Prof Tina Hartert, MD, MPH shared her insights on RSV in relationship to asthma. Her study of almost two thousand children has identified that delay in early life ...

Download

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Request for proposal

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn